Data suggests new Covid 19 strain brings increased risk of reinfection.
Pfizer and BioNTech are among the vaccine manufacturers insisting they'll be able adapt their products if the Omicron variant continues to spread.
Data suggests the new Covid 19 strain - first identified in South Africa - brings an increased risk of reinfection.
The World Health Organistation's calling it a "variant of concern".
But Jonathan Ball - a professor of molecular virology - says we shouldn't get ourselves into a "frenzy".

Corporation Tax Now Fuels One-Third Of State Income, Finance Minister Says It’s Not Reliable
Emergency Response Boost For Kildare As Firefighter-Paramedics Join Forces With First Responder Charity
“People With Disabilities Can Work”: Kildare Woman Challenges Workplace Assumptions
Jaguar Pulled Over For Frozen Windscreen, Impounded After Insurance Check
Former Kildare Town Car Dealer Convicted Of Misleading Buyer Over Vehicle History
Batches Of SMA Infant Formula Recalled Due To Potential Vomiting Risk
Tolls Increase On Congested M50 Sparks Protest
Fire Breaks Out At Funeral Home In Naas Town Centre